[1] Valdez JA, Brennan MT. Impact of oral cancer on quality of life [J]. Dent Clin North Am, 2018, 62(1):143-154. [2] 王丽萍,郭雪琪,闫勇勇,等.miR-146a在口腔鳞癌组织及细胞中的表达及功能研究[J].口腔医学研究,2017,33(11):1204-1208. [3] Oliveto S, Mancino M, Manfrini N, et al. Role of microRNAs in translation regulation and cancer [J]. World J Biol Chem, 2017, 8(1):45-56. [4] Shi JB, Bao X, Liu ZY, et al. Serum miR-626 and miR-5100 are promising prognosis predictors for oral squamous cell carcinoma [J]. Theranostics, 2019, 9(4): 920-931. [5] Yousef GA, Mark ER. RASSF1C regulates miR-33a and EMT marker gene expression in lung cancer cells [J]. Oncotarget, 2019, 10(2): 123-132. [6] Lu YC, Chang JT, Huang YC, et al. Combined determination of circulating miR-196a and miR-196b levels produces high sensitivity and specificity for early detection of oral cancer [J]. Clin Biochem, 2015, 48(3): 115-121. [7] Wang YH, Yin WJ, Lin YP, et al. Downregulated circulating microRNAs after surgery: potential noninvasive biomarkers for diagnosis and prognosis of early breast cancer [J]. Cell Death Discov, 2018, 4: 21. [8] Fu XD, Li YM, Alvero A, et al. MicroRNA-222-3p/GNAI2/AKT axis inhibits epithelial ovarian cancer cell growth and associates with good overall survival [J]. Oncotarget, 2016, 7(49): 80633-80654. [9] Yang CJ, Shen WG, Liu CJ, et al. miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells [J]. J Oral Pathol Med, 2011, 40(7): 560-566. [10] Seronde MF, Vausort M, Gayat E, et al. Circulating microRNAs and outcome in patients with acute heart failure [J]. PLoS One, 2015, 10(11): e0142237. [11] Tang X, Zeng X, Huang Y, et al. miR-423-5p serves as a diagnostic indicator and inhibits the proliferation and invasion of ovarian cancer [J]. Exp Ther Med, 2018, 15(6): 4723-4730. |